Ignite Creation Date:
2025-12-24 @ 11:38 PM
Ignite Modification Date:
2026-05-04 @ 5:12 PM
Study NCT ID:
NCT04922151
Status:
UNKNOWN
Last Update Posted:
2021-06-10
First Post:
2021-06-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
601 Versus Ranibizumab in Patients With Pathological Myopic Choroidal Neovascularization (pmCNV)
Sponsor:
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
SSGJ-601-pmCNV-II-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None